Liver-X-receptor agonism enhances T cell priming and activation to promote anti-tumor immunity

Journal of Experimental Medicine · Published 2026-01-14 · DOI 10.1084/jem.20252290

Authors being retrieved — see the publisher record. https://doi.org/10.1084/jem.20252290

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Oxysterols in Cancer: From Biosynthesis and Pathophysiology to Targeted Therapeutics · MedComm – Oncology · 2026 · Cites or is cited by this article
• Leveraging cDC1 biology and function for enhanced immunotherapy · Journal of Experimental Medicine · 2026 · Same journal
• Aquaporin-1 sustains lymphangiogenic responses in hyperosmotic inflammatory microenvironments · Journal of Experimental Medicine · 2026 · Same journal
• CNOT3 supports ILC2 differentiation and function by destabilizing Tbx21 and Rorc transcripts · Journal of Experimental Medicine · 2026 · Same journal
• Flawed translation triggers oncogenic B–T cell communication · Journal of Experimental Medicine · 2026 · Same journal
• Identification of secondary microglial formation centers in the human fetal brain · Journal of Experimental Medicine · 2026 · Same journal
• eIF3e-mediated translational checkpoint maintains immune tolerance and prevents lymphoid malignancy · Journal of Experimental Medicine · 2026 · Same journal
• Decoding TCR specificity and T cell fate at the immunological synapse · Journal of Experimental Medicine · 2026 · Same journal
• UBE2F impedes CD8 T cell memory · Journal of Experimental Medicine · 2026 · Same journal
• Chimeric allergen receptor regulatory T cells suppress birch pollen allergic airway inflammation · Journal of Experimental Medicine · 2026 · Same journal